Divi's Laboratories

quarterly
yearly
ParticularsSep '23Dec '23Mar '24Jun '24Sep '24
Revenue1,9531,9022,3382,1422,407
Expenses1,4891,4121,6381,5391,672
EBITDA559.00585.00796.00700.00834.00
EBIT465.00490.00702.00603.00736.00
Profit Before Tax464.00490.00700.00603.00735.00
Net Profit342.00358.00531.00430.00518.00
Financial Ratios
Operating Profit Margin29.93%32.36%35.24%33.93%36.23%
Net Profit Margin18.31%19.80%23.51%20.84%22.50%
Earning Per Share (Diluted)12.8913.5019.9916.1819.51
Dividends Per Share0.000.000.000.000.00
ⓒ 2016-2024 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 5.5.5
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  GROWWMF |  SBI |  AXIS |  HDFC |  UTI |  NIPPON INDIA |  ICICI PRUDENTIAL |  TATA |  KOTAK |  DSP |  CANARA ROBECO |  SUNDARAM |  MIRAE ASSET |  IDFC |  FRANKLIN TEMPLETON |  PPFAS |  MOTILAL OSWAL |  INVESCO |  EDELWEISS |  ADITYA BIRLA SUN LIFE |  LIC |  HSBC |  NAVI |  QUANTUM |  UNION |  ITI |  MAHINDRA MANULIFE |  360 ONE |  BOI |  TAURUS |  JM FINANCIAL |  PGIM |  SHRIRAM |  BARODA BNP PARIBAS |  QUANT |  WHITEOAK CAPITAL |  TRUST |  SAMCO |  NJ